1. Pharmacological implications of ipriflavone against environmental metal–induced neurodegeneration and dementia in rats
- Author
-
Hend M. Hussien, Hany E.A. Ahmed, Samar R. Saleh, Doaa A. Ghareeb, and Hani S. Hafez
- Subjects
Health, Toxicology and Mutagenesis ,medicine.medical_treatment ,Morris water navigation task ,Pharmacology ,Hippocampus ,medicine ,Amyloid precursor protein ,Animals ,Environmental Chemistry ,Cognitive decline ,Maze Learning ,Donepezil ,biology ,Chemistry ,Insulin ,Neurofibrillary tangle ,General Medicine ,medicine.disease ,Isoflavones ,Pollution ,Rats ,Molecular Docking Simulation ,Oxidative Stress ,Insulin receptor ,biology.protein ,Dementia ,Ipriflavone ,medicine.drug - Abstract
Long-term exposure to environmental neurotoxic metals is implicated in the induction of dementia and cognitive decline. The present study aims to illustrate the therapeutic role of ipriflavone as a synthetic isoflavone against environmental metal–induced cognitive impairment in rats. Dementia was induced by a mixture of aluminum, cadmium, and fluoride for 90 days followed by ipriflavone for a further 30 days. Metal-treated animals exhibited abnormal behaviors in the Morris water maze task. Neuropathological biomarkers including oxidative stress (TBARS, NO, SOD, GPX, GST, and GSH), inflammation (TNF- α, IL-6, and IL-1β), neurotransmission (AChE and MAO), and insulin resistance (insulin, insulin receptor, and insulin-degrading enzyme) were altered, which consequently elevated the level of amyloid-β42 and tau protein in the hippocampus tissues inducing neuronal injury. Ipriflavone significantly (P < 0.05) ameliorated the neurobehavioral abnormalities and the cognitive dysfunction biomarkers via antioxidant/anti-inflammatory mechanism. Moreover, ipriflavone downregulated the mRNA expression level of amyloid precursor protein and tau protein, preventing amyloid plaques and neurofibrillary tangle aggregation at P < 0.05. A molecular docking study revealed that ipriflavone has a potent binding affinity towards AChE more than donepezil and acts as a strong AChE inhibitor. Our data concluded that the therapeutic potential of ipriflavone against dementia could provide a new strategy in AD treatment.
- Published
- 2021
- Full Text
- View/download PDF